Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Clinica Hildebrand Brissago | OTHER |
| Neurocentro - Istituto di Neuroscienze Cliniche della Svizzera Italiana | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
It has been shown that patients with Parkinson's disease (PD) have impaired kinaesthesia and haptic perception of the upper limbs. In PD patients, these impairments might be involved in the development of hypometria or bradykinesia and may play a role in postural deficits, thereby significantly contributing to the overall disability level.
Dedicated conventional or robot-assisted training might improve sensory-motor function in PD patients. In order to provide efficient robot-assisted therapy, robotic devices have to be able to tailor the therapy difficulty to the individual impairment profile of each patient. For difficulty adaptation in robot-assisted therapy, it is important to assess the impairment profiles with the same robotic platform that would be used for therapy, therefore minimizing costs or potential errors coming from the use of different devices. However, up to now, little emphasis has been placed on providing sensory-motor robot-assisted therapy for the upper limbs to persons with PD based on their individual level of impairment.
The aim of this study is therefore to evaluate if the assessments of sensory-motor hand function implemented on a robotic device for hand rehabilitation, i.e. the ReHapticKnob, are suitable to measure the impairments of kinaesthesia and haptic perception observed in subjects with Parkinson's disease.
If the assessments implemented in the ReHapticKnob are sensitive enough to detect a difference between the sensory-motor function of PD patients and healthy subjects, the device might in the future be used to assess improvements before and after sensory-motor therapy. This is a necessary step before the investigators can use these assessments to tailor the difficulty level of the therapy performed with the ReHapticKnob and to investigate the benefits and impact of such a therapy on the kinaesthetic and haptic impairments of persons with PD.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Robotic assessment of sensory hand function | Experimental | This arm involves a group of persons with Parkinson's disease and an age-matched control group. Both groups undergo the assessments of kinaesthesia and haptic perception of the hand implemented on the ReHapticKnob. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Assessments of the hand sensory function with the ReHapticKnob | Device | During the assessment sessions with the ReHapticKnob, subjects sit comfortably on a chair in front of a screen and place the fingers of the hand on the handles of the device. The different assessments consist of moving the hand or forearm of the subjects to two different positions and asking the subject to discriminate between them (discrimination thresholds for the amplitude of grasping and forearm pronosupination positions), of passively moving the hand or forearm of the subject at low velocities and asking the subject to say when he/she detects the movement (detection thresholds for passive movements), or of rendering two objects with different stiffness and asking the subject to discriminate between them (discrimination thresholds for the stiffness of objects pinched with the hand). |
| Measure | Description | Time Frame |
|---|---|---|
| Detection threshold resulting from the assessment of detection of passive grasping movements - Right hand | Outcome of the assessment for the detection of passive grasping movements performed with the right hand. This threshold is expressed in time until movement detection. | Through study completion, an average of 2 weeks |
| Detection threshold resulting from the assessment of detection of passive grasping movements - Left hand | Outcome of the assessment for the detection of passive grasping movements performed with the left hand. This threshold is expressed in time until movement detection. | Through study completion, an average of 2 weeks |
| Detection threshold resulting from the assessment of detection of passive forearm pronosupination movements - Right forearm | Outcome of the assessment for the detection of passive forearm pronosupination movements performed with the right forearm. This threshold is expressed in time until movement detection. | Through study completion, an average of 2 weeks |
| Detection threshold resulting from the assessment of detection of passive forearm pronosupination movements - Left forearm | Outcome of the assessment for the detection of passive forearm pronosupination movements performed with the left forearm. This threshold is expressed in time until movement detection. | Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of just noticeable difference for grasping positions - Right hand | Outcome of the assessment for the discrimination of grasping positions performed with the right hand. This threshold is expressed in millimeters and represents the minimum difference that the subject can perceive. |
| Measure | Description | Time Frame |
|---|---|---|
| Demographic information | Gender, age, year of birth. | This information is collected during the screening visit performed at the beginning of the study (day 0). |
| Edinburgh Handedness Inventory Score |
Not provided
Ten patients with Parkinson's disease and 10 age-matched control subjects will be recruited.
Patients with Parkinson's disease: inclusion criteria
Diagnosis of idiopathic Parkinson's disease according to UK Parkinson's disease society brain bank clinical diagnostic criteria
Age between 35 and 80 years
Hoehn and Yahr stage of I, II or III during the ON state
Montreal Cognitive Assessment (MoCA) ≥ 26
No tremor, i.e.:
The subject read, understood and signed the informed consent
Patients with Parkinson's disease: exclusion criteria
Control subjects: inclusion criteria
Control subjects: exclusion criteria
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Daria Dinacci, Dr. med. | Clinica Hildebrand Centro di riabiliazione Brissago | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clinica Hildebrand, Centro di Rehabilitazione Brissago | Brissago | 6614 | Switzerland |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of just noticeable difference for grasping positions - Left hand | Outcome of the assessment for the discrimination of grasping positions performed with the left hand. This threshold is expressed in millimeters and represents the minimum difference that the subject can perceive. | Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of just noticeable difference for pronosupination positions - Right forearm | Outcome of the assessment for the discrimination of pronosupination positions performed with the right forearm. This threshold is expressed in degrees and represents the minimum difference that the subject can perceive. | Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of just noticeable difference for pronosupination positions - Left forearm | Outcome of the assessment for the discrimination of pronosupination positions performed with the left forearm. This threshold is expressed in degrees and represents the minimum difference that the subject can perceive. | Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of haptic perception - Right hand | Outcome of the assessment for haptic perception performed with the right hand. This threshold is expressed as Weber Fraction and represents the minimum difference in stiffness that the subject can perceive. | Through study completion, an average of 2 weeks |
| Discrimination threshold resulting from the assessment of haptic perception - Left hand | Outcome of the assessment for haptic perception performed with the left hand. This threshold is expressed as Weber Fraction and represents the minimum difference in stiffness that the subject can perceive. | Through study completion, an average of 2 weeks |
Questionnaire to define handedness.
| This information is collected during the screening visit performed at the beginning of the study (day 0).This information is collected during the screening visit performed at the beginning of the study (day 0). |
| Montreal Cognitive Assessment | Assessment of cognitive function (max score = 30, high score = better). | This information is collected during the screening visit performed at the beginning of the study (day 0).This information is collected during the screening visit performed at the beginning of the study (day 0). |
| Proprioception item of the Nottingham Sensory Assessment | Assessments used to characterize proprioception. | The control group does this assessment during the screening visit (day 0). The group of patients with Parkinson's disease does this during the second examination visit (day 0 to day 0 + 2 days). |
| MDS-Unified Parkinson's Disease Rating Scale: items 3.15 to 3.18 | Scale to characterize the state of the Parkinson's disease. This is done for the group of patients with Parkinson's disease only. These items are performed at the beginning as they are considered for the inclusion criteria. | This information is collected during the screening visit performed at the beginning of the study (day 0). |
| MDS-Unified Parkinson's Disease Rating Scale III | Scale to characterize the state of the Parkinson's disease. This is done for the group of patients with Parkinson's disease only. | This information is collected during the second examination visit (day 0 to day 0 + 2 days). |
| Hoehn and Yahr stage | Scale to characterize the state of the Parkinson's disease. This is done for the group of patients with Parkinson's disease only. | This information is collected during the screening visit performed at the beginning of the study (day 0). |
| Abnormal Involuntary Movement Scale | Scale to characterize the state of the Parkinson's disease. This is done for the group of patients with Parkinson's disease only. | This information is collected during the screening visit performed at the beginning of the study (day 0). |
| Levodopa equivalent daily dose | Information used to characterize the state of the Parkinson's disease and the timespan when the patient is in the ON state. This is collected for the group of patients with Parkinson's disease only. | This information is collected during the second examination visit (day 0 to day 0 + 2 days). |
| Disease onset | Information used to characterize the state of the Parkinson's disease. This is collected for the group of patients with Parkinson's disease only. | This information is collected during the second examination visit (day 0 to day 0 + 2 days). |
| Most affected side | Information used to characterize the side of the body most affected by the Parkinson's disease. This is collected for the group of patients with Parkinson's disease only. | This information is collected during the second examination visit (day 0 to day 0 + 2 days). |
| Frontal Assessment Battery | Assessment of cognitive function. This is collected for the group of patients with Parkinson's disease only. | This assessment is performed once during the study (from day 0 to day 0 + 25 days). |
| Attentive matrices | Assessment of cognitive function. This is collected for the group of patients with Parkinson's disease only. | This assessment is performed once during the study (from day 0 to day 0 + 25 days). |
| Digit span | Assessment of cognitive function. This is collected for the group of patients with Parkinson's disease only. | This assessment is performed once during the study (from day 0 to day 0 + 25 days). |
| Fatigue scale for motor and cognitive functions | Assessment of cognitive function. This is collected for the group of patients with Parkinson's disease only. | This assessment is performed once during the study (from day 0 to day 0 + 25 days). |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |